Docetaxel (taxotere) in the neoadjuvant setting for breast cancer:
Saved in:
| Format: | Book |
|---|---|
| Language: | English |
| Published: |
Philadelphia, PA
Saunders
1998
|
| Series: | Seminars in oncology
25,2, Suppl. 3 |
| Subjects: | |
| Physical Description: | 41 S. Ill. |
Staff View
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV011952582 | ||
| 003 | DE-604 | ||
| 005 | 20141210 | ||
| 007 | t | ||
| 008 | 980519s1998 a||| |||| 00||| eng d | ||
| 035 | |a (OCoLC)39039883 | ||
| 035 | |a (DE-599)BVBBV011952582 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-19 | ||
| 050 | 0 | |a RC280.B8 | |
| 245 | 1 | 0 | |a Docetaxel (taxotere) in the neoadjuvant setting for breast cancer |c [Monica Morrow guest ed. Contributors Harry D. Bear ...] |
| 264 | 1 | |a Philadelphia, PA |b Saunders |c 1998 | |
| 300 | |a 41 S. |b Ill. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 0 | |a Seminars in oncology |v 25,2, Suppl. 3 | |
| 650 | 7 | |a Borstkanker |2 gtt | |
| 650 | 7 | |a Docetaxel |2 gtt | |
| 650 | 4 | |a Antineoplastic Agents, Phytogenic |x therapeutic use | |
| 650 | 4 | |a Breast Neoplasms |x drug therapy | |
| 700 | 1 | |a Morrow, Monica |e Sonstige |0 (DE-588)173193544 |4 oth | |
| 700 | 1 | |a Bear, Harry D. |e Sonstige |4 oth | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-008081087 | ||
Record in the Search Index
| _version_ | 1804126540257034240 |
|---|---|
| any_adam_object | |
| author_GND | (DE-588)173193544 |
| building | Verbundindex |
| bvnumber | BV011952582 |
| callnumber-first | R - Medicine |
| callnumber-label | RC280 |
| callnumber-raw | RC280.B8 |
| callnumber-search | RC280.B8 |
| callnumber-sort | RC 3280 B8 |
| callnumber-subject | RC - Internal Medicine |
| ctrlnum | (OCoLC)39039883 (DE-599)BVBBV011952582 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01042nam a2200325 cb4500</leader><controlfield tag="001">BV011952582</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20141210 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">980519s1998 a||| |||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)39039883</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV011952582</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC280.B8</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Docetaxel (taxotere) in the neoadjuvant setting for breast cancer</subfield><subfield code="c">[Monica Morrow guest ed. Contributors Harry D. Bear ...]</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Philadelphia, PA</subfield><subfield code="b">Saunders</subfield><subfield code="c">1998</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">41 S.</subfield><subfield code="b">Ill.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Seminars in oncology</subfield><subfield code="v">25,2, Suppl. 3</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Borstkanker</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Docetaxel</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antineoplastic Agents, Phytogenic</subfield><subfield code="x">therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Breast Neoplasms</subfield><subfield code="x">drug therapy</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Morrow, Monica</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)173193544</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bear, Harry D.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-008081087</subfield></datafield></record></collection> |
| id | DE-604.BV011952582 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T18:19:04Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-008081087 |
| oclc_num | 39039883 |
| open_access_boolean | |
| owner | DE-19 DE-BY-UBM |
| owner_facet | DE-19 DE-BY-UBM |
| physical | 41 S. Ill. |
| publishDate | 1998 |
| publishDateSearch | 1998 |
| publishDateSort | 1998 |
| publisher | Saunders |
| record_format | marc |
| series2 | Seminars in oncology |
| spelling | Docetaxel (taxotere) in the neoadjuvant setting for breast cancer [Monica Morrow guest ed. Contributors Harry D. Bear ...] Philadelphia, PA Saunders 1998 41 S. Ill. txt rdacontent n rdamedia nc rdacarrier Seminars in oncology 25,2, Suppl. 3 Borstkanker gtt Docetaxel gtt Antineoplastic Agents, Phytogenic therapeutic use Breast Neoplasms drug therapy Morrow, Monica Sonstige (DE-588)173193544 oth Bear, Harry D. Sonstige oth |
| spellingShingle | Docetaxel (taxotere) in the neoadjuvant setting for breast cancer Borstkanker gtt Docetaxel gtt Antineoplastic Agents, Phytogenic therapeutic use Breast Neoplasms drug therapy |
| title | Docetaxel (taxotere) in the neoadjuvant setting for breast cancer |
| title_auth | Docetaxel (taxotere) in the neoadjuvant setting for breast cancer |
| title_exact_search | Docetaxel (taxotere) in the neoadjuvant setting for breast cancer |
| title_full | Docetaxel (taxotere) in the neoadjuvant setting for breast cancer [Monica Morrow guest ed. Contributors Harry D. Bear ...] |
| title_fullStr | Docetaxel (taxotere) in the neoadjuvant setting for breast cancer [Monica Morrow guest ed. Contributors Harry D. Bear ...] |
| title_full_unstemmed | Docetaxel (taxotere) in the neoadjuvant setting for breast cancer [Monica Morrow guest ed. Contributors Harry D. Bear ...] |
| title_short | Docetaxel (taxotere) in the neoadjuvant setting for breast cancer |
| title_sort | docetaxel taxotere in the neoadjuvant setting for breast cancer |
| topic | Borstkanker gtt Docetaxel gtt Antineoplastic Agents, Phytogenic therapeutic use Breast Neoplasms drug therapy |
| topic_facet | Borstkanker Docetaxel Antineoplastic Agents, Phytogenic therapeutic use Breast Neoplasms drug therapy |
| work_keys_str_mv | AT morrowmonica docetaxeltaxotereintheneoadjuvantsettingforbreastcancer AT bearharryd docetaxeltaxotereintheneoadjuvantsettingforbreastcancer |